Special Issue Article
Received 30 June 2013,
Accepted 29 October 2013
Published online 18 December 2013 in Wiley Online Library
(wileyonlinelibrary.com) DOI: 10.1002/jlcr.3147
18
2-Bromo-6-[ F]fluoropyridine: two-step
fluorine-18 radiolabelling via transition metal-
mediated chemistry†
a,d,e
Helen M. Bettsa,b,c and Edward G. Robins
*
Novel radiolabelling methods are important for the development of new tracers for positron emission tomography. Direct
nucleophilic fluorination of aromatic rings with [18F]fluoride is limited to activated substrates, restricting the application of this
approach. Inspired by transition metal-mediated transformations, a fluorine-18 synthon was prepared to supplement the
radiolabelling methods available for molecules unsuitable for direct labelling. 2-Bromo-6-[18F]fluoropyridine (denoted [18F]1)
was prepared in high yield, and palladium-mediated cross-coupling reactions were exemplified. High incorporation of fluoride
and efficient cross-coupling reactions demonstrate that compound [18F]1 holds promise as a new synthon for construction of
fluorine-18-labelled molecules via transition metal-mediated reactions.
Keywords: PET; fluorine-18; synthon; 2-Fluoropyridine; palladium; cross-coupling
reported, but these synthons have not been widely adopted as
Introduction
they are either prepared in moderate yield from the symmetrical
Positron emission tomography (PET) is a valuable imaging
dihalobenzene or from iodonium salts, which require complex
precursor syntheses, and can be prone to side reactions.4–6
technique for monitoring physiological processes in vivo in a
[18F]Fluorinated heteroaromatics such as [18F]fluoropyridines
non-invasive manner, using concentrations of radiolabelled
compounds that do not cause a pharmacological response.1
have become more prevalent as the heteroatom can be used
The most widely available isotope for PET imaging is fluorine-
to tune a potential PET tracer’s pharmacokinetic profile. In some
18, which has a half life of 109.7 min and is readily produced as
cases, heteroaromatics are more amenable to
a direct
aqueous fluoride from a cyclotron. Although the moderate half
life is ideal for patient scanning without excessive radiation
burden, it presents a challenge for the radiochemist to prepare
and purify [18F]fluorine-labelled imaging agents within a short
window.
radiolabelling approach, although the presence of electron
withdrawing groups is preferred.7
Molecules of interest for PET imaging commonly feature the
fluorine radiolabel as a fluoroaromatic group. Direct nucleophilic
[18F]fluorination of aromatic ring systems requires the presence
of electron withdrawing substituents, and harsh reaction
conditions are employed for efficient incorporation.2 Multistage
synthon approaches provide an alternative in which an activated
precursor is radiolabelled and subsequently incorporated into
the molecule of interest. Popular synthons include 4-[18F]
fluorobenzaldehyde and N-succinimidyl-4-[18F]fluorobenzoate.
However, these synthons are limited to labelling molecules with
a reactive nucleophile for conjugation, and their purification
from by-products can be difficult.3 Novel methods of
radiolabelling aromatic systems with [18F]fluoride are therefore
of interest.
This article describes the synthesis and transition metal-
mediated reactions of the novel synthon 2-bromo-6-[18F]
fluoropyridine. Transition metal-mediated approaches have
often been reported in carbon-11 radiosyntheses (t1/2 = 20 min,
β+) to selectively assemble reaction components in good yield;
however, relatively few examples exist for [18F]fluorine
radiolabelling.1 Notably, palladium-mediated reactions of [18F]
fluorobromo benzene and [18F]fluoroiodobenzene have been
aGE Healthcare Discovery, Medical Diagnostics, Cyclotron Building,
Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK
bGE Healthcare Discovery, Medical Diagnostics, The Grove Centre, White Lion
Road, Amersham, Bucks, HP7 9LL, UK
cNottingham University Hospitals NHS Trust, PET/CT Centre, Nottingham City
Hospital, Nottingham, NG5 1PB, UK
dSingapore Bioimaging Consortium (SBIC) Agency for Science, Technology and
Research (A*STAR) 11 Biopolis Way, Helios Building, Singapore 138667
eClinical Imaging Research Centre (CIRC), Yong Loo Lin School of Medicine,
Centre for Translational Medicine, National University of Singapore, 14 Medical
Drive, Singapore, 117599
*Correspondence to: Helen M. Betts, Nottingham University Hospitals NHS Trust,
PET/CT Centre, Nottingham City Hospital, Nottingham, NG5 1PB, UK.
E-mail: helen.betts@nottingham.ac.uk
† This article is published in the Journal of Labelled Compounds and
Radiopharmaceuticals as a special issue on ‘Current Developments in PET and
SPECT Imaging’, edited by Jonathan R. Dilworth, University of Oxford and Sofia
I. Pascu, University of Bath.
J. Label Compd. Radiopharm 2014, 57 215–218
Copyright © 2013 John Wiley & Sons, Ltd.